explore -WSS

explore

author：entertainment 2025-10-01 02:16:22 - browse：6

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Medical records are filled with copy
Next article： Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

WSS

Attacks on the drug industry will lead to fewer breakthroughs

TytoCare raises $49 million to build out AI

Mirador, a new biotech startup, launches with $400 million

For BCIs, commercial hurdles may be bigger than scientific ones

Yancopoulos of Regeneron works to expand Dupixent success

Biden calls for immediate release of Niger's president amid apparent coup

leisure time

explore

hotspot

Medicare details structure of new drug price negotiation program

Nearly two

Activists slam private health insurers over coverage restrictions

6 surprising facts about sugar

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Virginia high school admissions case could be legal follow

Influencer to be charged after chaos erupts in New York City's Union Square

The cancer drug shortage isn’t new — and neither are the solutions

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

Steward Health Care expansion into Malta flopped

6 surprising facts about sugar

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Medical devices makers are asking for forgiveness, not permission

OTC birth control: A brief history of over the counter pill design

What Henrietta Lacks settlement says about racism in medicine

leisure time

focus

hotspot

explore